Abstract: The present invention relates to compounds of the following general formula (I) or (II) or a pharmaceutically acceptable salt and/or solvate thereof, for use in the prevention and/or the treatment of disorders associated to gammaherpesvirinae, in particular to the human herpesvirus 8 (HHV8) or the human herpes virus 4 (HHV4), and pharmaceutical compositions containing such compounds.
Type:
Grant
Filed:
June 28, 2017
Date of Patent:
November 24, 2020
Assignees:
Assistance Publique—Hopitaua de Paris, Institut National de la Sante et de la Recherche Medicale (INSERM), Sorbonne Unicersite, Universite Paris Descartes, Centre National de la Recherche Scientifique (CNRS)
Inventors:
Nicolas Dupin, Anne-Geneviève Marcelin, Vincent Calvez, Philippe Grange